Innovations in Personalised Medicine: Towards implementation of personalised medicine in healthcare
Personalised medicine is an interdisciplinary field that will drive the health research and innovation agenda for years to come. Research and innovation in this area is moving rapidly, but in a rather fragmented fashion. The implementation of personalised medicine in health care is moving forward in areas such as cancer, where most successful opportunities have been identified, but progress is slow within most other indication areas.
Partnerships and innovation networks are needed to encourage cross-disciplinary and cross-border collaboration in order to advance the field. It is of the utmost importance that research, industry, health care sectors and society jointly address challenges related to regulatory and legal frameworks, policy, payment mechanisms and health economics, etc., to overcome barriers to the implementation of PM.
This call is specifically aimed at developing innovations related to the implementation of personalised medicine for citizens and health care systems. It is intended to build on strengths and synergies between the Nordic countries.
Who can apply?
The following applicants from the Nordic countries can apply for funding (the Nordic countries are defined here as
Denmark, Finland, Iceland, Norway, Sweden):
• Research organisations including academic research and research institutes
• Public organisations including hospitals, regulatory agencies, municipalities etc.
• Small-, medium- and large private enterprises
• Patient organisations
The call will open for applications on 13 April.
Total budget for the call is EUR 14.9 million.
Read more here.